SENTINEL CH. SpA
6 recall(s) on record — most severe on record: Class II.
Recalls by year
- Recalls (6)
Registered facilities (1)
- SENTINEL CH. SPA FEI 3000303338 · IT
Recalls & enforcement
- Class IIOngoing2023-09-29A high recovery of Iron assay has been observed at some customer sites. Internal studies confirmed the positive shift of Quality Control and patient samples results, up to 15% for Iron Products (Alinity c Iron Reagent REF. 08P3920) to be used on Abbott Alinity Instrument and to …
- Class IIITerminated2021-07-29Calibrator vials were incorrectly labeled. Use of incorrectly labeled vials will cause the instrument to generate a warning that calibrators are incorrectly loaded and calibration will not be completed successfully.
- Class IIIOngoing2021-04-30Claim for stability after reconstitution from lyophilized to liquid form does not meet the requirements. New IFU instructions for handling the product provided to end users.
- Class IITerminated2019-06-28Added an additional SmartWash parameter for the Lithium and Alinity c Lithium Reagent Kit, catalogue number 8L25-30 and 08P5320 to prevent the potential for carryover from the ARCHITECT Lactate Dehydrogenase (LDH) reagent (LN 2P56) may result infalsely elevated lithium patient …
- Class IITerminated2017-05-22Reagent 1 component may result in Quality Control values shifting out of acceptable range, which is not resolved by recalibration.
- Class IITerminated2015-09-22Results for ammonia are below the linear range of the assay for samples that have been collected in sodium or lithium heparin tubes.
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. We restate the public record only — measured facts, never risk verdicts.
Cite this record
RegWarden. “SENTINEL CH. SpA — FDA compliance profile.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/company/oo-9025279-sentinel-ch-spa/
Alerts for SENTINEL CH. SpA
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.